Clinical trials show retatrutide, Eli Lilly's new triple-agonist drug, delivered 24.2% weight loss in 48 weeks and the ...

What started out as a medication for diabetes and weight loss is offering something quite unexpected for many women. Experts ...

As Novo Nordisk launches first FDA-approved oral weight loss medication, independent examination evaluates Ro's ...

In a Monday interview with CNBC's Jim Cramer, Novo Nordisk CEO Mike Doustdar suggested the new pill format of the ...

Discontinuing obesity medicines often means the weight comes back and people lose the cardiovascular and metabolic benefits ...

The Wegovy pill comes in tablet form—and is the first U.S. Food & Drug Administration (FDA)-approved GLP-1 to do so. Its ...

What are GLP-3s? Weight loss drugs are more effective than current popular jabs in clinical trials - One in eight Americans ...

Cutaneous adverse events associated with GLP-1 receptor agonists are uncommon but vary by agent, a study of FDA data shows.

And in a phase III trial win, Foresee Pharmaceuticals said its long-acting gonadotropin-releasing hormone agonist leuprolide ...

According to an article posted by the Yale School of Medicine in July 2024, “The first drug in a class known as GLP-1 ...

BANGKOK: Thailand's Food and Drug Administration (FDA) is seeking to tighten oversight of GLP-1 injection "slimming pens", ...